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[~H]V~s~pr~ssin binding to rat hi~~~carnpal synaptic plasma 
Received 4 September I983 
Characterization of specific vasopressin binding sites to rat hi~pocamp~l membranes has been assayed 
using tridated l~s~~e-va$o~~ess~R labekd on the tyrosyl residue, At 30°C specific [3H]vasopressin binding 
was saturable. The estimated e~~~~br~~~ dissociation constant was 7.1 n&I, the mean maximal binding 
capacity was 73 fmoIimg protein. Argi~i~e-vasopressio has B high affinity (l&t = 2.8 nM) and dDAVP 
has a low affinity f& = 249 nM) for hipp~campal synaptic membranes. @H)AVP and Phe%IcasVT are 
at least as active as AVF in inhibiting [3~]v~sopressin binding, Adenylate cyclase was acitvated by VIP 
and inhibited by FIA, but not affected by lysine-v~op~~ss~n. 
1 s INTRODUCTION 
Vasopressia and oxytocin are not only neuro- 
b~physea~ hormones carried by a vascular route 
to affect peripheral target tissues but they may also 
have neural functions. This view is based on: 
The demonstration of their presence in sy~ap~ 
tic endings of extrahypaphyseal pathways 111; 
The existence of a ~~~iurn-dependents de- 
poIar~~a,tjon-induced r lease of oxytodn and 
vasopressin from brain slices [Z]; 
The observations that neurohypophys~~ pep- 
tides have several behavioral effects including 
an influence on the retention of conditioned 
avoidance tasks in rats (review [3f; 
The demonstration of several (both excitatory 
and inhibitory) eiectraphysiological effecrts of 
applied oxytocin and vasopressin 141. 
very b~~pfu~ for e~~~idati~g thestill poorly under- 
stood role of neurohypophyseal peptides on brain 
function 1st. 
We report the characterization of specific 
vasopressin binding sites in the rat hippocampus, 
The choice of this brain region was dictated by: 
Qxytocin and vasopressin containing fibers 
being identified in this region [6]; 
~ip~~~pus might be a possible site of ac- 
tion for vasopressin acting on memory proces- 
ses; 
~ippocampa~ ~~urones respond to applied 
vasopressin and axytocin f4]. 
Binding studies for neuro~~ophyseal peptides 
in the central nervous system have not yet been 
reported, Such studies would be of ~rnport~~ce for
the analysis of structure-beading relationships and 
the design of pharmacologicat tools which could be 
2, MATERIALS AND METHUDS 
2. f * ~~~~pfos~~~~ membrane ~~~~~r~f~~~ 
Animals used were male Wistar rats (200 g body 
wt) purchased from IFFA CREDO (Lyon). For 
each experiment he hippocampi from 20 rat brains 
were dissected and immersed in ice-cold 0.32 M 
sucrose:. The tissue: (I.7 g) was homogenized in a 
Potter homogenizer equipped with a perspex pestle 
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(0.25 mm clearance) as in [7]. 
Synaptic piasma membranes were prepared as in 
[S]. Briefly a crude synaptosom~ fraction was 
prepared and submitted to an osmotic shock in 
5 mM Tris-HCl buffer fpH 8.1) for 30 min at 
0°C. Membranes were separated by flotation in a 
discontinuous sucrose gradient (34al0, 28.5% and 
10010, w/w) and collected at the 34%-28.5% inter- 
face after centrifugation at 60000 x g for 110 min. 
The membranes were dispersed in 50 mM 
Tris-HCl (PH 7,4), 5 mM MgCL, washed and 
resuspended in the same medium to a concentra- 
tion of about 2 mg protein/ml. For some adenyf- 
ate cyclase assays membranes were prepared with 
ECTA, 1 mM present at all steps of the above pro- 
cedure. All experiments were performed using 
freshly prepared membranes. 
2.2. [31f] Vmopressin binding assay 
[lysine-3HjVasopressin labelled on the tyrosyl 
residue in position 2 was prepared as in [9] and 
purified by affinity chromatography on a neuro- 
physin-Sepharose column [ 101. Radiochemical 
purity was checked by high-pressure liquid ehro- 
matography on a Beckman ultrasphere ODS re- 
versed-phase column. Elution was performed with 
a linear 40 min gradient of lo-50% B at 
1 ml/min. Solvent A was 0.1 Yo trifluoroacetic acid 
(pH 3.5) and solvent B 0.1% triiruoroacetic acid in 
75% acetonitrile. The purified peptide had a speci- 
fic radioactivity of 8.5 CilmM and biological acti- 
vities undistinguishable from those of the purified 
starting material (synthetic lysine-vasopressin from 
Bachem). 
Membranes (SO-150 gg protein/assay) were in- 
cubated in a final voh,rme of 200~1 of a medium 
composed of 50 mM Tris-HCl (PH 7,4), 5 mM 
MgCI2, 1 mg bovine serum albumin/ml and 
various amounts of [3H~vasopressin. Non-specific 
binding was determined in the presence of 1OpM 
unlabelled lysine-vasopressin. incubation was per- 
formed at 30°C for 20 min. Bound labelled 
vasopressin was separated by filtration through 
Gelman membrane filters (Metricel GA-3; 
1.2 pm). Filters were washed 3 times by 5 ml 
10 mM Tris-HC1 (pH 7.4), 1 mM MgCL, 
Radioactivity retained on the filter was counted by 
Liquid scintillation spe~trometry. All determina- 
tions were performed in triplicates. 
The dissociation constants for unlabelled vaso- 
pressin and analogues were deduced from the 
determination of the dose-dependent inhibition of 
~3H~v~opressin (10 nM) binding. 
Control expe~ments indicated that: 
(1) 
(2) 
(3) 
(4) 
[3H]Vasopressin was not inactivated during 
the course of incubation in the presence of 
membranes ~ina~ivation was checked by 
HPLC analysis); 
The specific and non-specific components of 
[3H]vasopressin binding increased linearly 
with up to 3OOhg membrane protein/assay; 
At 10 nM, a value close to the observed 
dissociation constant, the non-specific compo- 
nent of ~3H]v~opressin binding represented 
54 + 8% of total binding (9 expt); 
Freezing the membr~es in liquid nitrogen 
resulted in a 50% decrease in vasopressin bin; 
ding capacity. 
2.3. Adenylate cyclase assay 
The adenylate cyclase activity of the hippocam- 
pal membranes was determined as follows: mem- 
branes (30ag protein/assay) were incubated in a 
final volume of lOO,& of a medium containing 
50 mM Tris-HCl (pH 7.4), 0.5 mM MgC12, 
O-25 mM ATP, 1 mM CAMP, 0.1 mM papaverine, 
0.08 IU adenosine deaminase/ml, 1.5 mg creatine 
phosphate/m~, 1 mg creatine kinaselml, 1 mg 
bovine serum albumin/ml, f32P]ATP 0.5 ,&i/ 
assay, c[‘H]AMP 2 nCi/assay. ~terminations 
were performed in the presence and absence of 
0.1 mM CTP and 0.1 mM GTP + 0.2 M NaCI. 
The membranes were incubated for 10 min at 
3O’C. The reaction was initiated by adding t3’P]- 
ATP under a small volume (10~1) and stopped 
S min later by addition of 1 ml of a solution 
containing: 2@?0 sodium dodecyl sulfate, 50 mM 
Tris-HC1 (pH 7.4), 5 x 10v4 M CAMP, 
3.3 x 1O-4 M ATP. 
2.4. Peptldes wed 
The formulae and biological activities of the 
vasopressin structural anaiogues used are indicated 
in table 1. 
3. RESULTS AND DISCUSSION 
Specific r3H]vasopressin binding to rat hip- 
pocampaf synaptic plasma membranes was a fairly 
slow process. At 30°C and for 10 nM ligand, a 
401 
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Table 1 
Affinity constants for binding of vasopressin and analogues to hippocampal synaptic plasma membranes: relation to 
antidiuretic and vasopressor activities 
Peptide Relative biological activitie? Binding to hippocampal membrane 
Arginine vasopressin (AVP) 
Lysine vasopressin (LVP) 
Oxytocin (OXY) 
I-(L-2-hydroxy-3-mercapto- 
propanoic acid)-Arginine 
vasopressin ((OH) AVP) 
[2-phenylalanine, %ornithine]- 
Vasotocin (PheZOrn*VT) 
l-Deamino[&D-arginine]-vaso- 
pressin (dDAVP) 
[ I-@-mercapto-fl&cyclopenta- 
methylene propionic acid), 
2-0-ethyltyrosine, 4-valinel- 
Vasopressin 
(d(CH&Tyr(et)VAVP) 
[ 1 -t&mercapto-fl&cyclopenta- 
methylene propionic acid), 
2-0-ethyhyrosine, 4-valine, 
8-D-argininel-Vasopressin 
(d(CHz)sTyr(et)VDAVP 
Antidiureticb Vasopressorb 
100 100 
88 73 
1.3 1.1 
146 
0.17 
371 
Antagonist Antagonist 
A2 = 45 nM’ A2=7nMc 3.6 79 
Antagonist 
,A2 = 79 nMC 
149 
33 
0.1 
Antagonist 
A2=5nMC 29 10 
J& (nWd 
2.8 
7.1 
45.3 
Relative affinitya 
100 
40 
6 
0.9 313 
5.9 48 
249 1 
a Percent of AVP takenas a standard 
b Values used for the calculation of relative vasopressor and antidiuretic activities were taken from [13] 
’ A2 is the antagonist concentration leading the response to 2 x X concentration of agonist to equal that of 1 x X 
agonist concentration 
d The dissociation constants for the unlabelled peptides (Kd) was deduced from Zse-values; i.e., concentrations of 
unlabelled peptide leading to half-maximal inhibition of [‘Hlvasopressin-specific binding, using the following relation 
Kd = Iso x &[3H]LVP/(&[3H]LVP) + ([3H]LVP), in which &[3H]LVP is the dissociation constant for 
[3H]vasopressin bi ding and ([‘H]LVP) the concentration of [3H]vasopressin in the incubation medium 
value close to the equilibrium dissociation cons- 
tant, a maximum value was reached within 15 min 
and was stable thereafter up to 40 min. The 
estimated half-time was about 5 min. The cor- 
responding value at 2O’C was 8 min. All further 
experiments were performed at 30°C and the dura- 
tion of membrane incubation in the presence of 
[3H]vasopressin was 20 min. 
Specific [3H]vasopressin binding was saturable. 
The results shown in fig.1 indicate that dose- 
dependent binding was observable in a concentra- 
tion range covering about two orders of 
magnitude. The Scatchard plot of the dose-bind- 
ing curve did not show a clear deviation from 
linearity suggesting that vasopressin binds to an 
apparently homogeneous population of specific 
binding sites. The estimated equilibrium dissocia- 
tion constant was 7.1 nM, a value which is close to 
those determined for vasopressin receptors charac- 
terized in peripheral organs (review [ll]). 
The mean maximal binding capacity of 
78 fmol/mg protein is lower than those found for 
402 
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Fig. 1. Dose-dependency for specific ~3H]vasopressin 
binding to purified hippocampal synaptic plasma 
membranes. The binding assay was conducted as in 
section 2. Left: Specific [3H]vasopressin binding is 
plotted as a function of the [3H]vasopressin 
concentration in the incubation medium (log-scale). 
Values on the graphs are means of 3 inde~ndent 
experiments. Right: Scatchard plots of dose-binding 
curves shown in the left panel. Values of the dissociation 
constants and maximal binding capacities estimated 
from the calculated regression lines are 7.1 nM and 
78 fmol/mg protein, respectively. 
1.0 
0 r m . 
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Fig.2. Dose-dependent inhibition of [3H]vasopressin 
binding to hippocampal synaptic plasma membranes by 
unlabelled peptides. Membranes were incubated in the 
presence of a constant amount of [3H]vasopressin 
(10 nM) and increasing amounts of unlabelled peptides, 
5 different concentrations of unlabelled peptides were 
tested. Vaiues of specific binding measured in the 
presence of unlabelled peptides (S) were expressed as a 
fraction of the specific binding measured in the absence 
of competitor (I&,). Each point is the mean of triplicate 
The two vasopressin antagonists tested were able 
to inhibit [3H]vasopressin binding to hippocampal 
membranes. For d(CH&Tyr(et)VAVP the ap- 
parent dissociation constant is closer to the A2 
value for the inhibition of the vasopressor esponse 
in vivo than to the corresponding value for the in- 
hibition of the antidiuretic response. For 
d(CH&Tyr(et)VDAVP the estimated dissociation 
constant appeared to be half-way between the A2 
values for the inhibition of the antidiuretic and 
vasopressor esponses. The dissociation constants 
for the binding of the two antago~sts tested were 
determined on liver membranes which were shown 
to contain vasopressin receptors of the VI 
(vasopressor) type. The results obtained (not 
shown) indicated that the affinity of 
d(CH&Tyr(et)VDAVP was about 10 times less 
than the affinity of d(CH2)5Tyr~et)VAVP. This 
figure compares very well with the results obtained 
on rat hippocampal membranes (see table 1). 
determinations. These data indicate that the recognition pattern 
kidney or hepatic membranes. This could indicate 
that vasopressin receptors are not expressed by all 
hippocampal neurones. Glial localization is unlike- 
ly. Indeed the method used for synaptic plasma 
membrane preparation exclude the larger part of 
glial elements. 
The detected vasopressin binding sites exhibited 
a high degree of specificity. Unlabelled vasopressin 
and the vasopressin structural analogues tested in- 
hibited [3H]vasopressin binding to almost the same 
maximal extent but exhibited marked differences 
in efficiency. From the data in fig.2 and table 1 it 
can 
(1) 
(2) 
(3) 
be concluded that: 
Arginine-vasopressin is more efficient than 
lysine-vasopressin (& estimated to 2.8 nM as 
compared to 7.1 nM for lysine-vasopressin); 
dDAVP known as a selective antidiuretic pep- 
tide has a low affinity for hippoc~p~ synap- 
tic membranes; 
The two analogues (OH) AVP and 
Phe2-Orn’-VT which exhibit a high 
vasopressor/antidiuretic activities ratio are 
almost as active (Phe20rn8VT) or more active 
((OH) AVP) than AVP in inhibiting 
[‘H]vasopressin binding. 
For the entire series of agonist tested there was 
a fairly good correspondence between their relative 
vasopressor activities and their relative affinities 
for hippocampal membranes. 
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Table 2 
Adenylate cyclase activity in hippocampal synaptic plasma membranes 
Additions Control membranes EGTA-treated membranes 
+GTP 0.1 mM +GTP 0.1 mM Without GTP +GTPO.l mM 
+ NaCl 0.2 M and NaCl + NaCl 0.2 M 
None 349 + 23 334 * 53 101 + 16 157 f 12 
VIP 1 pM 485 f 8a 462 + 21a _ - 
PJA 5 nM - - 104 ? 6 NS 153 + 9 NS 
50 nM 340 + 11 NS 281 f 2 NS 102 + 6 NS 128 + 8a 
5/4M 319 + 17 NS 280 f 6 NS 103 f 7 NS 112 + ga 
LVP 10 nM - 97 f 9 NS 169& 6NS 
100 nM _ 99 * 7 NS 165 + 4 NS 
10 PM 384 f 25 NS 357 + 6 NS 100 * 6 NS 162 + 8 NS 
Values in the table are means f SD of 4-5 determinations. Adenylate cyclase activities are expressed 
in pmol cyclic AMP formed.min-‘.mg protein-‘. Values determined in the presence of vasoactive 
intestinal polypeptide (VIP), phenylisopropyladenosine (PIA) or lysine vasopressin (LVP) were 
compared to the corresponding basal values using Student’s t-test (NS, non-significant; a p < 0.05) 
of hippocampal vasopressin binding sites exhibits 
marked similarities with that of the so-called VI 
type of vasopressin receptors present on vascular 
smooth muscle cells and hepatocytes. 
The results from the adenylate cyclase ex- 
periments are summarized in table 2. Under ex- 
perimental conditions where an activation of en- 
zyme activity by vasoactive intestinal polypeptide 
(membranes incubated in the presence of GTP) 
and inhibition by phenylisopropyladenosine 
(EGTA-treated membranes incubated in the 
presence of GTP plus NaCI) could be demon- 
strated, vasopressin did not change adenylate 
cyclase activity. This suggests that vasopressin 
receptors in the hippocampus, unlike renal VZ 
receptors but like VI vascular and hepatic recep- 
tors, are not functionally coupled to adenylate 
cyclase. 
This study shows the existence in the rat hip- 
pocampus of specific vasopressin binding sites 
which have several similarities with previously 
characterized VI vasopressin receptors. They might 
represent physiological receptors responsible for 
vasopressin actions in the hippocampus. 
A study which demonstrated a close correlation 
between the vasopressor effects of vasopressin 
structural analogues and their effects on memory 
consolidation [12], led to the conclusion that 
404 
vasopressin might influence avoidance behaviour 
through its effects on blood pressure. If the 
detected hippocampal vasopressin receptors, 
resembling the vasopressin receptors from blood 
vessels, are those which might be involved in these, 
still controversial, effects of vasopressin on 
memory, then our results would indicate that one 
can hardly argue from investigations uch as those 
conducted in [12] that vasopressin, influences 
behaviour through a peripheral action. 
Furthermore, our results might indicate that 
both vasopressin and oxytocin receptors are pre- 
sent in the hippocampus. Indeed recent phar- 
macological studies [4] clearly indicated that the 
receptors involved in the increased firing rate of 
hippocampal interneurones have a specificity very 
close to that of uterine oxytocin receptors. 
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